Article

ifa Systems acquires inoveon

ifa Systems AG has acquired inoveon Corp. ifa Systems provides ophthalmology-related software applications, including an electronic health record system that has been adopted in Europe and Latin America and now has been introduced into the North American and Asian markets. inoveon Corp. is a medical services company focused on managing diabetic eye disease, clinical research, and development.

Oklahoma City, OK-ifa Systems AG has acquired inoveon Corp.

ifa Systems provides ophthalmology-related software applications, including an electronic health record system that has been adopted in Europe and Latin America and now has been introduced into the North American and Asian markets. inoveon Corp. is a medical services company focused on managing diabetic eye disease, clinical research, and development.

The two companies previously have collaborated in developing open clinical and health information technology standards. The merger is expected to broaden ifa’s product line and distribution structure and further its international market share in 17 countries managing more than 70 million patients’ data.

The merger also means that Oklahoma City will become a hub for international telemedicine activities for inoveon, including service development and consulting activities. The inoveon platform will be extended, and its services will expand to include new ones for ifa’s installed client base.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.